×

CPRD StudyPrimary Care PASS Study

Risk Factors of Major Bleeding in Patients Prescribed Rivaroxaban in Primary Care in England

The association between oral anticoagulant use and bleeding risk has been widely reported.

CPRD StudyPrimary Care PASS Study

The Association between Direct Oral Anticoagulants and Gynaecological Bleeding in Women v. Standard Therapy: A Systematic Review

Women receiving anticoagulation are susceptible to the added risk of gynaecological bleeding (GB).

CPRD StudyPrimary Care PASS Study

Utilisation Of Dulaglutide In Primary Care In England: Interim Results From A Post Authorisation Safety Study

Dulaglutide is a once-weekly injectable long acting glucagon-like peptide-1 receptor agonist (GLP-1 RA) authorised in England for the treatment of type 2 diabetes mellitus (T2DM).

CPRD StudyPrimary Care PASS Study

Utilisation of Exenatide Once-Weekly (Bydureon®) in Primary Care in England: Results From a PASS

Bydureon® was largely used in accordance with prescribing recommendations in 1o care in England, with most frequent use in pts with poor diabetic control where treatment with alternative ADMs may have been unsuccessful.

CPRD StudyPrimary Care PASS Study

Monitoring the Safety of Exenatide Once-Weekly (Bydureon®) in Primary Care in England: Results from a PASS

Incidence of AP was low in Bydureon® users and consistent with prior clinical trial/observational data.

CPRD StudyPrimary Care PASS Study

Impact Analyses of European Pharmacovigilance Interventions on Public Health Burden

This interim analysis tested a method for predicting public health impact of PV interventions on a subset of products based on drug utilisation data and expected changes in morbidity.

CPRD StudyPrimary Care PASS Study

Characterisation of Drug Interaction Related Signals Leading to EU Regulatory Action and a Methodological Review of Novel Drug Interaction Signal Detection Methods in the Post-Marketing Setting

Characterisation of Drug Interaction Related Signals Leading to EU Regulatory Action and a Methodological Review of Novel Drug Interaction Signal Detection Methods in the Post-Marketing Setting.